Recombinant Mouse FGF-16 Protein
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-61333
Product Specifications
Description
A single non-glycosylated polypeptide chain containing 207 amino acids corresponding to FGF-16 Source: E. coli
Amino Acid Sequence: MAEVGGVFAS LDWDLHGFSS SLGNVPLADS PGFLNERLGQ IEGKLQRGSP TDFAHLKGIL RRRQLYCRTG FHLEIFPNGT VHGTRHDHSR FGILEFISLA VGLISIRGVD SGLYLGMNER GELYGSKKLT RECVFREQFE ENWYNTYAST LYKHSDSERQ YYVALNKDGS PREGYRTKRH QKFTHFLPRP VDPSKLPSMS RDLFRYR
Purity
>98%, by SDS-PAGE and HPLC
Endotoxin Level
Less than 0.1 EU/ug of FGF-16 as determined by LAL method.
Predicted Molecular Mass
23.8 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Activity
Data not available.
Protein / Peptide Type
Recombinant Protein
Formulation, Preparation and Storage
NBP2-61333
Formulation | 0.2 um filtered solution in 20 mM Tris-HCl, pH 9.0, 1 M NaCl, 0.02 % Tween-20, 10 % Glycerol. |
Concentration | Please see the vial label for concentration. If unlisted please contact technical services. |
Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Store at -20C. Avoid freeze-thaw cycles. |
Background: FGF-16
Long Name
Fibroblast Growth Factor 16
Alternate Names
FGF16
Gene Symbol
FGF16
Additional FGF-16 Products
Product Documents for Recombinant Mouse FGF-16 Protein
Product Specific Notices for Recombinant Mouse FGF-16 Protein
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...